U.S. Patent Disclosures
Novosom AG, of Halle, Germany, received U.S. Patent No. 7,371,404, titled "Amphoteric liposomes and their use." It covers Smarticles, which are fully charged reversible liposomes for the in vivo delivery of nucleotides such as siRNA or antisense to targeted cells.
Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No. 7,374,752, titled "Reovirus for the Treatment of Cellular Proliferative Disorders," which covers pharmaceutical compositions comprising various recombinant reoviruses.
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-770-810-3144
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter